- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Basigin antibody, also known as CD147 antibody, recognizes a type I transmembrane glycoprotein encoded by the human BSG gene located on chromosome 19p13.3. Basigin is a member of the immunoglobulin superfamily and is widely referred to in the literature as CD147, Emmprin, and Extracellular matrix metalloproteinase inducer. Basigin is predominantly localized to the plasma membrane, where it regulates cell-cell adhesion, extracellular matrix remodeling, and intercellular signaling. Basigin antibody is frequently used in research examining tumor progression, inflammation, and metabolic adaptation.
CD147 contains two extracellular immunoglobulin-like domains, a single transmembrane region, and a short cytoplasmic tail. Through its extracellular domains, Basigin interacts with integrins, cyclophilins, and matrix metalloproteinases, promoting extracellular matrix degradation and stromal activation. The Emmprin designation reflects its ability to stimulate matrix metalloproteinase production in neighboring fibroblasts, contributing to tissue remodeling and invasive growth. Basigin antibody supports studies focused on these matrix-associated signaling mechanisms and tumor-stroma interactions.
Basigin is broadly expressed in epithelial cells, endothelial cells, leukocytes, and numerous tumor cell types. Elevated CD147 expression has been documented in breast, lung, colorectal, hepatocellular, and head and neck cancers, where increased levels are associated with angiogenesis, tumor invasion, and metastatic potential. In addition to its role in matrix remodeling, Basigin forms complexes with monocarboxylate transporters, facilitating lactate export in highly glycolytic tumor cells and supporting metabolic reprogramming. Basigin antibody is therefore commonly applied in research investigating tumor metabolism and hypoxic microenvironments.
Beyond oncology, CD147 participates in immune and inflammatory responses. It functions as a receptor for extracellular cyclophilins and contributes to leukocyte activation and chemotaxis. Expression is also observed in reproductive tissues and during development, reflecting broader roles in tissue remodeling and differentiation. Clone BSG/7952 is designed to recognize CD147 for research applications. This antibody targets Basigin in research settings and supports studies of cancer biology, inflammation, and metabolic regulation.
Optimal dilution of the Basigin/CD147 antibody should be determined by the researcher.
Recombinant full-length human protein was used as the immunogen for the Basigin/CD147 antibody.
Aliquot the Basigin/CD147 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.